Trials / Completed
CompletedNCT05547490
A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis
Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Patients With Moderate-To-Severe Plaque Psoriasis in Real-World Settings in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,506 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to achieve a better understanding of clinical characteristics, treatment patterns and clinical outcomes of participants with moderate-to-severe plaque psoriasis (PsO) as well as their unmet medical needs and disease burden in real-world setting in China.
Conditions
Timeline
- Start date
- 2022-10-31
- Primary completion
- 2023-04-28
- Completion
- 2023-04-28
- First posted
- 2022-09-21
- Last updated
- 2023-12-18
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05547490. Inclusion in this directory is not an endorsement.